118. Myelomeningocele
9 clinical trials,   15 drugs   (DrugBank: 7 drugs),   8 drug target genes,   11 drug target pathways
Searched query = "Myelomeningocele", "Myeloschisis", "Myelocele", "Myelocystocele", "Syringomyelocele"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00175123 (ClinicalTrials.gov) | May 2005 | 9/9/2005 | Effect of Botulinum Toxin in Neurogenic Bladders in Children With Myelomeningocele | Phase 4 Study of the Effect of Botulinum-A Toxin Injected in Neurogenic Overactive Bladders of Children Born With Myelomeningocele | Myelomeningocele;Bladder, Neurogenic | Drug: Botulinum A toxin | University of Aarhus | Aarhus University Hospital | Active, not recruiting | 2 Years | 16 Years | Both | 30 | Phase 4 | Denmark |